ISDS Case Map
India
The Canadian government is putting pressure on India to fast-track a bilateral trade deal at a time when both countries are negotiating a nuclear deal.
Malaysia and India are on target to sign a free-trade agreement by year-end as the two countries readied for a third round of talks.
The Delhi Network of Positive People (DNP+) is calling on the EU Trade Commissioner to come clean on the demands and pressures being placed by the European Union on the Government of India to accept TRIPS-plus measures that will have a severe, adverse impact on access to safe, effective and affordable medicines in India and across the developing world.
Commerce minister Anand Sharma said on Monday that a proposed free-trade agreement (FTA) with the European Union (EU) would not hurt the generic drugs industry. The minister also said India would attract the same amount of foreign direct investment as last year.
US Trade Representative Ron Kirk and Indian Minister of Commerce and Industry Anand Sharma signed a framework cooperation agreement on trade and investment on 17 March 2010
As informal talks have started between India and Europe on the free trade agreement (FTA) in New Delhi since Monday, apprehensions over provisions that could impact early access to generic medicines are being voiced in Thailand.
CENTAD, in partnership with the Heinrich Böll Foundation, have come out recently with 4 reports on trade and gender. The first is a backgrounder (literature review) while the other three are on the gender impact of the EU-India FTA in the fields of agriculture, services and health.
The feasibility study on the Indo-Australian Free Trade Agreement (FTA) will be finalised by April this year with both governments expected to begin negotiations soon, according to a top Australian official.
With the looming threat of these supply lines being disrupted by TRIPS+ provisions that are likely to be demanded of the Indian Government by FTA negotiators from the European Union and Japan we request that the Indian Government stand firm on their position of refusing all TRIPS+ provision that maybe included in any final agreement.
India-EU free-trade pact may limit cheap drugs
